Literature DB >> 7719903

Elevated levels of circulating tumor necrosis factor alpha in human immunodeficiency virus type 1-infected Africans living in Sweden.

A Sönnerborg1, S Ayehunie, I Julander.   

Abstract

Elevated levels of tumor necrosis factor alpha in serum were found in human immunodeficiency virus type 1 (HIV-1)-infected Africans to a higher extent than in matched HIV-1-infected Caucasians, both groups living in Sweden. The results suggest that factors not related to the environment contribute to enhanced synthesis of tumor necrosis factor alpha in HIV-1-infected patients.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7719903      PMCID： PMC170111          DOI： 10.1128/cdli.2.1.118-119.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  10 in total

1.  Enhancement of HIV replication and giant cell formation by tumor necrosis factor.

Authors:  T Matsuyama; H Yoshiyama; Y Hamamoto; N Yamamoto; G Soma; D Mizuno; N Kobayashi
Journal:  AIDS Res Hum Retroviruses       Date:  1989-04       Impact factor: 2.205

2.  Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor.

Authors:  J E Merrill; Y Koyanagi; I S Chen
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

3.  Who will get AIDS?

Authors:  H Wachter; D Fuchs; A Hausen; G Reibnegger; E R Werner; M P Dierich
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

4.  Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection.

Authors:  M von Sydow; A Sönnerborg; H Gaines; O Strannegård
Journal:  AIDS Res Hum Retroviruses       Date:  1991-04       Impact factor: 2.205

5.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

Authors:  J Lähdevirta; C P Maury; A M Teppo; H Repo
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

6.  Comparative humoral responses to HIV-1 p24gag and gp120env in subjects from East Africa and the UK.

Authors:  P Kaleebu; R Cheingsong-Popov; D Callow; E Katabira; F Mubiru; B Biryahwaho; S Sempala; C Gilks; R Brindle; J B Were
Journal:  AIDS       Date:  1991-08       Impact factor: 4.177

7.  Tumor necrosis factor and severe malaria.

Authors:  N Shaffer; G E Grau; K Hedberg; F Davachi; B Lyamba; A W Hightower; J G Breman; N D Phuc
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

8.  Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia.

Authors:  S Ayehunie; A Sonnerborg; T Yemane-Berhan; D W Zewdie; S Britton; O Strannegard
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

9.  Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis.

Authors:  P Pisa; M Gennene; O Söder; T Ottenhoff; M Hansson; R Kiessling
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

10.  Differential elevation of circulating interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states.

Authors:  L Bélec; D Meillet; A Hernvann; G Grésenguet; R Gherardi
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.